TLX - Telix Pharmaceuticals - Stock Forecast

Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

TLX is currently covered by 1 analysts with an average price target of $20.79. This is a potential upside of $3.99 (23.75%) from yesterday's end of day stock price of $16.8.

Telix Pharmaceuticals's activity chart (see below) currently has 0 price targets and 2 ratings on display. The stock rating distribution of TLX is 100% BUY.

Stock Analyst Price Targets - Review

Highest price target for TLX is $22, Lowest price target is $22, average price target is $22.

Most recent stock forecast was given by LAURA SUTCLIFFE from UBS on 27-Jan-2025. First documented stock forecast 15-Nov-2024.

Best performing analysts who are covering TLX - Telix Pharmaceuticals:

Laura Sutcliffe

Currently out of the existing stock ratings of TLX, 2 are a BUY (100%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Laura Sutcliffe (UBS)

Buy

$22

$5.91 (36.73%)

$21

4 months 21 days ago
(27-Jan-2025)

0/2 (0%)

$3.99 (22.15%)

Please subscribe to see the analyst performance score

Show more analysts

Load Price Targets and Ratings Chart

To gain access for the analyst/ stock price target chart please use a computer

What is TLX (Telix Pharmaceuticals) average time for price targets to be met?

On average it took 0 days on average for the stock forecasts to be realized with a an average price target met ratio 0

Which analyst has the current highest performing score on TLX (Telix Pharmaceuticals) with a proven track record?

LAURA SUTCLIFFE

Which analyst has the most public recommendations on TLX (Telix Pharmaceuticals)?

Laura Sutcliffe works at UBS and has 7 price targets and 4 ratings on TLX

Which analyst is the currently most bullish on TLX (Telix Pharmaceuticals)?

Laura Sutcliffe with highest potential upside - $5.91